Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 nov. 2022 04h00 HE | Source: Alvotech

Alvotech birtir rannsókn á útskiptileika AVT02 líftæknilyfjahliðstæðu við Humira® á ráðstefnu Bandarísku gigtarlæknasamtakanna

Alvotech mun halda þrjár kynningar sem tengjast rannsókn á útskiptileika AVT02Rannsóknin var gerð til að kanna lyfjahvörf, klíníska virkni, öryggi og þolanleika í sjúklingum sem skiptu endurtekið á...
10 nov. 2022 04h00 HE | Source: Alvotech

Alvotech to Present Switching Study Data for AVT02, a Proposed Biosimilar to Humira®, at 2022 American College of Rheumatology Conference

Alvotech will present two posters and will be featured in an Ignite Talk related to its switching study for ATV02The switching study was conducted to investigate the pharmacokinetics,...